149 related articles for article (PubMed ID: 30202756)
41. Hormonal replacement therapy and evaluation of intrauterine pathology in postmenopausal women: a ten-year study.
Mossa B; Imperato F; Marziani R; Perniola F; Melluso J; Perniola G; Napolitano C
Eur J Gynaecol Oncol; 2003; 24(6):507-12. PubMed ID: 14658591
[TBL] [Abstract][Full Text] [Related]
42. Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study.
Sinawat S; Chiyabutra T
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S59-63. PubMed ID: 21218592
[TBL] [Abstract][Full Text] [Related]
43. Guidelines for monitoring patients taking tamoxifen treatment.
Neven P; Vernaeve H
Drug Saf; 2000 Jan; 22(1):1-11. PubMed ID: 10647972
[TBL] [Abstract][Full Text] [Related]
44. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients.
Tepper R; Beyth Y; Altaras MM; Zalel Y; Shapira J; Cordoba M; Cohen I
Gynecol Oncol; 1997 Mar; 64(3):386-91. PubMed ID: 9062139
[TBL] [Abstract][Full Text] [Related]
45. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
46. [Hysteroscopic evaluation of the uterine cavity in postmenopausal women with uterine bleeding].
Wierzbowski T; Gottwald L; Bieńkiewicz A; Suzin J
Ginekol Pol; 2003 Sep; 74(9):892-6. PubMed ID: 14674141
[TBL] [Abstract][Full Text] [Related]
47. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
[TBL] [Abstract][Full Text] [Related]
48. Hysteroscopic evaluation of the endometrium of post-menopausal patients with breast cancer before and after tamoxifen use.
Gonçalves MA; Gonçalves WJ; Matias MM; Nazario AC; de Lima GR; Baracat EC
Int J Gynaecol Obstet; 1999 Sep; 66(3):273-9. PubMed ID: 10580675
[TBL] [Abstract][Full Text] [Related]
49. [Ambulatory hysteroscopy in evaluation of postmenopausal bleeding].
Wieser F; Albrecht A; Kurz C; Wenzl R; Nagele F
Wien Klin Wochenschr; 1999 Apr; 111(7):289-93. PubMed ID: 10355040
[TBL] [Abstract][Full Text] [Related]
50. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer.
López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC
Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254
[TBL] [Abstract][Full Text] [Related]
51. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients.
Giorda G; Crivellari D; Veronesi A; Perin T; Campagnutta E; Carbone A; Scarabelli C
Acta Obstet Gynecol Scand; 2002 Oct; 81(10):975-80. PubMed ID: 12366490
[TBL] [Abstract][Full Text] [Related]
52. Transvaginal sonography versus hysteroscopy in evaluation of abnormal uterine bleeding.
Goyal BK; Gaur I; Sharma S; Saha A; Das NK
Med J Armed Forces India; 2015 Apr; 71(2):120-5. PubMed ID: 25859072
[TBL] [Abstract][Full Text] [Related]
53. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
[TBL] [Abstract][Full Text] [Related]
54. Hysteroscopy and transvaginal ultrasonography in postmenopausal women with uterine bleeding.
Garuti G; Sambruni I; Cellani F; Garzia D; Alleva P; Luerti M
Int J Gynaecol Obstet; 1999 Apr; 65(1):25-33. PubMed ID: 10390096
[TBL] [Abstract][Full Text] [Related]
55. Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen.
Beşe T; Kösebay D; Demirkiran F; Arvas M; Beşe N; Mandel N
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):157-62. PubMed ID: 8841805
[TBL] [Abstract][Full Text] [Related]
56. [Tamoxifen and endometrial disease in patients with breast cancer].
Dalbert DB; Rodríguez de la Peña MM; Figueredo A; Mural J; Bartt O; Subiela R; Rossi C; Bazán G
Medicina (B Aires); 2013; 73(2):97-103. PubMed ID: 23570756
[TBL] [Abstract][Full Text] [Related]
57. Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma.
Juneja M; Jose R; Kekre AN; Viswanathan F; Seshadri L
Int J Gynaecol Obstet; 2002 Mar; 76(3):279-84. PubMed ID: 11880131
[TBL] [Abstract][Full Text] [Related]
58. Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study.
Fong K; Causer P; Atri M; Lytwyn A; Kung R
Radiographics; 2003; 23(1):137-50; discussion 151-5. PubMed ID: 12533649
[TBL] [Abstract][Full Text] [Related]
59. Comparative study of transvaginal ultrasonography and hysteroscopy in postmenopausal bleeding.
Alcázar JL; Laparte C
Gynecol Obstet Invest; 1996; 41(1):47-9. PubMed ID: 8821885
[TBL] [Abstract][Full Text] [Related]
60. Comparative study of transvaginal sonography and hysteroscopy for the detection of pathologic endometrial lesions in women with postmenopausal bleeding.
Karlsson B; Granberg S; Hellberg P; Wikland M
J Ultrasound Med; 1994 Oct; 13(10):757-62. PubMed ID: 7823337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
